Director Kenneth J Kelley sold $814K of Halozyme Therapeutics, Inc.

Sold$813,850

$41.37Price

19,671Shares

−7%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Wed, Nov 25. Filed Fri, Nov 27, 12:43 PM ET, during the session. Not investment advice.